AI-Based Cancer Detection Model for Contrast-Enhanced Mammography
Bioengineering · 2023-08-17 · 10 (8) · 974
DOI: 10.3390/bioengineering10080974 ↗At a glance
Journal article in Bioengineering, published online on 2023-08-17. Written by Clément Jailin and 9 co-authors. Institution: GE HealthCare, 283 Rue de la Miniére, 78530 Buc, France. Cited 23 times so far (Crossref); 48 references. The full text is freely available (open access, CC BY 4.0). Funded by: GE HealthCare.
Abstract (original language)
Background
The recent development of deep neural network models for the analysis of breast images has been a breakthrough in computer-aided diagnostics (CAD). Contrast-enhanced mammography (CEM) is a recent mammography modality providing anatomical and functional imaging of the breast. Despite the clinical benefits it could bring, only a few research studies have been conducted around deep-learning (DL) based CAD for CEM, especially because the access to large databases is still limited. This study presents the development and evaluation of a CEM-CAD for enhancing lesion detection and breast classification. Materials & Methods: A deep learning enhanced cancer detection model based on a YOLO architecture has been optimized and trained on a large CEM dataset of 1673 patients (7443 images) with biopsy-proven lesions from various hospitals and acquisition systems. The evaluation was conducted using metrics derived from the free receiver operating characteristic (FROC) for the lesion detection and the receiver operating characteristic (ROC) to evaluate the overall breast classification performance. The performances were evaluated for different types of image input and for each patient background parenchymal enhancement (BPE) level.
Results
The optimized model achieved an area under the curve (AUROC) of 0.964 for breast classification. Using both low-energy and recombined image as inputs for the DL model shows greater performance than using only the recombined image. For the lesion detection, the model was able to detect 90% of all cancers with a false positive (non-cancer) rate of 0.128 per image. This study demonstrates a high impact of BPE on classification and detection performance.
Conclusion
The developed CEM CAD outperforms previously published papers and its performance is comparable to radiologist-reported classification and detection capability.
Subjects
Author keywords
Authors and institutions
- GE HealthCare, 283 Rue de la Miniére, 78530 Buc, France.
- Baheya Foundation for Early Detection and Treatment of Breast Cancer, El Haram, Giza 78530, Egypt.
- National Cancer Institute, Cairo University, 1 Kasr Elainy Street Fom Elkalig, Cairo 11511, Egypt.
- Radiology Department, Kasr El Ainy Hospital, Cairo University, Cairo 11511, Egypt.
ORCID profiles: Clément Jailin
Funding
- GE HealthCare
Cite
APA
Jailin, C., Mohamed, S., Iordache, R., Milioni De Carvalho, P., Ahmed, S. Y., Abdel Sattar, E. A., Moustafa, A. F. I., Gomaa, M. M., Kamal, R. M., & Vancamberg, L. (2023). AI-Based Cancer Detection Model for Contrast-Enhanced Mammography. Bioengineering, 10(8), 974. https://doi.org/10.3390/bioengineering10080974
Vancouver
Jailin C, Mohamed S, Iordache R, Milioni De Carvalho P, Ahmed SY, Abdel Sattar EA, et al. AI-Based Cancer Detection Model for Contrast-Enhanced Mammography. Bioengineering. 2023;10(8):974. doi:10.3390/bioengineering10080974
BibTeX
@article{Jailin2023,
author = {Jailin, Clément and Mohamed, Sara and Iordache, Razvan and Milioni De Carvalho, Pablo and Ahmed, Salwa Yehia and Abdel Sattar, Engy Abdullah and Moustafa, Amr Farouk Ibrahim and Gomaa, Mohammed Mohammed and Kamal, Rashaa Mohammed and Vancamberg, Laurence},
title = {AI-Based Cancer Detection Model for Contrast-Enhanced Mammography},
journal = {Bioengineering},
year = {2023},
volume = {10},
number = {8},
pages = {974},
doi = {10.3390/bioengineering10080974}
}
EUVIMED